给药装置的全球市场：按给药途径、按应用、按最终用户、按地区

预计2024年全球给药器材市场规模将达2,102亿美元，2024年至2031年复合年增长率为8.8%，2031年将达3,791.1亿美元。

图：2024 年按地区分類的药物输送设备市场占有率(%)

药物输送装置是指用于在体内输送药物化合物的各种技术。有效的药物传递可确保活性药物成分在作用部位达到正确的浓度。有助于提高药物疗效和患者依从性。生技药品、个人化医疗的快速发展以及慢性病的增加可能会增加对先进药物输送系统的需求。专注于提高安全性、准确性和易用性的药物传输设备的持续技术创新可能会在不久的将来推动市场成长。

市场动态：

全球给药装置市场的成长是由糖尿病、癌症和心血管疾病等慢性病盛行率上升所推动的。老年人口的增加和医疗保健支出的增加也推动了市场的成长。然而，开发先进输送系统的高成本可能会阻碍市场成长。创新产品的监管障碍也可能阻碍市场成长。新兴国家为市场进入者提供了利润丰厚的机会。对自助注射器和居家医疗的需求不断增长可能是市场成长的机会。携带式和可穿戴输送系统的持续技术进步也提供了成长机会。采用物联网智慧设备是关键的市场趋势。

本研究的主要特点

该报告对全球给药装置市场进行了详细分析，包括以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。 。

它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、绩效和策略等参数，包括全球药物输送设备市场主要企业的概况。

本研究涵盖的主要企业包括 Becton、Dickinson and Company、Baxter International、Pfizer、Gerresheimer、Nemera 等。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球药物输送设备市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过用于分析全球给药设备市场的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规及趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章 全球给药设备市场，依给药途径，2019-2031 年（十亿美元）

• 口服
• 胃肠外的
• 经皮的
• 眼睛

第五章 2019-2031 年全球药物传输设备市场（按应用划分）（十亿美元）

• 肿瘤学
• 感染疾病
• 呼吸系统疾病
• 糖尿病
• 心血管疾病
• 自体免疫疾病
• 中枢神经系统疾病

第六章 全球给药设备市场，依最终使用者划分，2019-2031 年（十亿美元）

• 医院
• 诊断中心
• 门诊手术中心/诊所
• 家庭护理设置
• 其他的

第七章 2019-2031 年全球药物输送设备市场（按地区）（十亿美元）

• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第八章 竞争格局

• Abbott Laboratories
• Adherium Ltd.
• Amiko Digital Health Limited
• Becton, Dickinson and Company
• BIOCORP
• CeQur Corporation
• Cognita Labs
• E3D Elcam Drug Delivery Devices
• H&T Presspart Manufacturing Ltd.
• HCmed Innovations Co., Ltd.
• Medtronic plc
• Novo Nordisk A/S
• Phillips-Medisize
• Sonceboz
• Enable Injections, Inc.
• NOVO Engineering
• Elcam Medical
• Battelle
• Gerresheimer AG
• Aphios

第九章 分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第10章 参考文献与调查方法

• 参考
• 调查方法
• 出版商

Global drug delivery device market is estimated to be valued at USD 210.20 Bn in 2024 and is expected to reach USD 379.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

Figure. Drug Delivery Device Market Share (%), By Region 2024

Drug delivery device refers to various technologies used to transport pharmaceutical compounds in the body. Effective drug delivery ensures availability of right concentrations of active pharmaceutical ingredients at the site of action. It helps improve efficacy of drugs and patient compliance. Rapid developments in biologics, personalized medicine and increasing prevalence of chronic diseases can boost demand for advanced drug delivery systems. Constant innovations in drug delivery devices focused on enhancing safety, precision and ease-of-use can drive the market growth in the near future.

Market Dynamics:

Global drug delivery device market growth is driven by rising incidence of chronic illnesses such as diabetes, cancer and cardiovascular diseases. Growing geriatric population and increasing healthcare spending also drives the market growth. However, high costs associated with development of advanced delivery systems can hamper the market growth. Regulatory hurdles for innovative products can also hamper the market growth. Emerging economies offer lucrative opportunities for market players. Escalating demand for self-administered injection devices and home healthcare can offer market growth opportunities. Continued technological advancements in portable and wearable delivery systems can also offer growth opportunities. Adoption of smart devices enabled with internet of things is a key trend in the market.

Key features of the study:

This report provides in-depth analysis of the global drug delivery device market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug delivery device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, and Nemera

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global drug delivery device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery device market

Detailed Segmentation-

• By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
  • Oral
  • Parenteral
  • Transdermal
  • Ocular
  • Pulmonary
• By Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
• By End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Others
• By Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott Laboratories
  • Adherium Ltd.
  • Amiko Digital Health Limited
  • Becton, Dickinson and Company
  • BIOCORP
  • CeQur Corporation
  • Cognita Labs
  • E3D Elcam Drug Delivery Devices
  • H&T Presspart Manufacturing Ltd.
  • HCmed Innovations Co., Ltd.
  • Medtronic plc
  • Novo Nordisk A/S
  • Phillips-Medisize
  • Sonceboz
  • Enable Injections, Inc.
  • NOVO Engineering
  • Elcam Medical
  • Battelle
  • Gerresheimer AG
  • Aphios

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Drug Delivery Device Market, By Route of Administration
  • Global Drug Delivery Device Market, By Application
  • Global Drug Delivery Device Market, By End User
  • Global Drug Delivery Device Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Drug Delivery Device Market, By Route of Administration, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Transdermal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ocular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pulmonary
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Drug Delivery Device Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Respiratory Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Autoimmune Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Central Nervous System Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Drug Delivery Device Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Surgery Centers/Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Drug Delivery Device Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Adherium Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amiko Digital Health Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BIOCORP
• CeQur Corporation
• Cognita Labs
• E3D Elcam Drug Delivery Devices
• H&T Presspart Manufacturing Ltd.
• HCmed Innovations Co., Ltd.
• Medtronic plc
• Novo Nordisk A/S
• Phillips-Medisize
• Sonceboz
• Enable Injections, Inc.
• NOVO Engineering
• Elcam Medical
• Battelle
• Gerresheimer AG
• Aphios

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us